日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

YAP1 defines an emergent, plastic population of relapsed small cell lung cancer

YAP1定义了复发性小细胞肺癌中一种新兴的、可塑性的细胞群。

Stewart, C Allison; Ramkumar, Kavya; Wang, Runsheng; Xi, Yuanxin; Halliday, Alexa; Diao, Lixia; Wang, Qi; Serrano, Alejandra; Groves, Sarah; Heeke, Simon; Tanimoto, Azusa; Kaiser, Laura; Lewis, Whitney; Bose, Mukulika; Da Rocha, Pedro; Karacosta, Loukia; Quaranta, Vito; Wang, Jing; George, Julie; Solis Soto, Luisa Maren; Zhang, Bingnan; Heymach, John V; Byers, Lauren A; Gay, Carl M

DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer

DNA损伤反应特征与广泛期小细胞肺癌的一线化疗反应和肿瘤演变途径相关

Morris, Benjamin B; Heeke, Simon; Xi, Yuanxin; Diao, Lixia; Wang, Qi; Rocha, Pedro; Arriola, Edurne; Lee, Myung Chang; Tyson, Darren R; Concannon, Kyle; Ramkumar, Kavya; Stewart, C Allison; Cardnell, Robert J; Wang, Runsheng; Quaranta, Vito; Wang, Jing; Heymach, John V; Nabet, Barzin Y; Shames, David S; Gay, Carl M; Byers, Lauren A

The Impact of Targeting TRAF2 and NCK-Interacting Protein Kinase on Antitumor Effect and Tumor Immune Environment in c-MYC-High SCLC

靶向TRAF2和NCK相互作用蛋白激酶对c-MYC高表达小细胞肺癌抗肿瘤效应和肿瘤免疫微环境的影响

Tanimoto, Azusa; Ramkumar, Kavya; Stewart, C Allison; Zhang, Bingnan; Concannon, Kyle; Cardnell, Robert J; Shen, Li; Wang, Qi; Wang, Jing; Gay, Carl M; Byers, Lauren Averett

YAP1 defines an emergent, plastic population of relapsed small cell lung cancer.

YAP1 定义了复发性小细胞肺癌中一种新兴的、可塑性强的细胞群。

Stewart C Allison, Ramkumar Kavya, Wang Runsheng, Xi Yuanxin, Halliday Alexa, Diao Lixia, Wang Qi, Serrano Alejandra, Groves Sarah, Heeke Simon, Tanimoto Azusa, Kaiser Laura, Lewis Whitney, Bose Mukulika, Da Rocha Pedro, Karacosta Loukia, Quaranta Vito, Wang Jing, George Julie, Solis Soto Luisa Maren, Zhang Bingnan, Heymach John V, Byers Lauren A, Gay Carl M

YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities.

YAP1 状态定义了 LCNEC 的两种内在亚型,它们具有不同的分子特征和治疗脆弱性

Stewart C Allison, Diao Lixia, Xi Yuanxin, Wang Runsheng, Ramkumar Kavya, Serrano Alejandra G, Tanimoto Azusa, Rodriguez B Leticia, Morris Benjamin B, Shen Li, Zhang Bingnan, Yang Yan, Hamad Samera H, Cardnell Robert J, Duarte Alberto Jr, Sahu Moushumi, Novegil Veronica Y, Weissman Bernard E, Frumovitz Michael, Kalhor Neda, Solis Soto Luisa, da Rocha Pedro, Vokes Natalie, Gibbons Don L, Wang Jing, Heymach John V, Glisson Bonnie, Byers Lauren Averett, Gay Carl M

Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial

西妥昔单抗联合阿维鲁单抗治疗非小细胞肺癌患者的抗肿瘤活性涉及先天免疫激活:CAVE-Lung试验结果

Della Corte, Carminia Maria; Fasano, Morena; Ciaramella, Vincenza; Cimmino, Flora; Cardnell, Robert; Gay, Carl M; Ramkumar, Kavya; Diao, Lixia; Di Liello, Raimondo; Viscardi, Giuseppe; Famiglietti, Vincenzo; Ciardiello, Davide; Martini, Giulia; Napolitano, Stefania; Tuccillo, Concetta; Troiani, Teresa; Martinelli, Erika; Wang, Jing; Byers, Lauren; Morgillo, Floriana; Ciardiello, Fortunato

A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers

癌症DNA损伤的警钟:Schlafen 11 (SLFN11) 在多种癌症中的作用

Zhang, Bingnan; Ramkumar, Kavya; Cardnell, Robert John; Gay, Carl Michael; Stewart, C Allison; Wang, Wei-Lien; Fujimoto, Junya; Wistuba, Ignacio I; Byers, Lauren Averett

STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype

STING通路表达可识别具有免疫反应表型的非小细胞肺癌

Della Corte, Carminia M; Sen, Triparna; Gay, Carl M; Ramkumar, Kavya; Diao, Lixia; Cardnell, Robert J; Rodriguez, Bertha Leticia; Stewart, C Allison; Papadimitrakopoulou, Vassiliki A; Gibson, Laura; Fradette, Jared J; Wang, Qi; Fan, Youhong; Peng, David H; Negrao, Marcelo V; Wistuba, Ignacio I; Fujimoto, Junya; Solis Soto, Luisa M; Behrens, Carmen; Skoulidis, Ferdinandos; Heymach, John V; Wang, Jing; Gibbons, Don L; Byers, Lauren A